Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05420584
What this trial is testing

Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 83
Large-scale testing (Phase 3)Study completedNCT02399306
What this trial is testing

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 222
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Large-scale testing (Phase 3)UnknownNCT00154752
What this trial is testing

Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Post-approval studies (Phase 4)UnknownNCT05897749
What this trial is testing

Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment

Who this might be right for
Colorectal CancerChinese Herbal MedicineProgression-free Survival+1 more
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60
Testing effectiveness (Phase 2)UnknownNCT06564298
What this trial is testing

A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis

Who this might be right for
Stomach Neoplasms
The First Affiliated Hospital with Nanjing Medical University 39
Testing effectiveness (Phase 2)Study completedNCT02106884
What this trial is testing

Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel

Who this might be right for
Pancreatic Cancer
Universitaire Ziekenhuizen KU Leuven 146
Large-scale testing (Phase 3)Study completedNCT01500993
What this trial is testing

Capecitabine in the Perioperative Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Universitätsmedizin Mannheim 401
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Not applicableUnknownNCT05002452
What this trial is testing

Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 150
Early research (Phase 1)Ended earlyNCT05395052
What this trial is testing

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerBreast Cancer+4 more
Fate Therapeutics 5
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT01149434
What this trial is testing

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Who this might be right for
CancerNeuroendocrineOvarian Cancer+1 more
University of Utah 19
Testing effectiveness (Phase 2)Looking for participantsNCT07468071
What this trial is testing

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Who this might be right for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerAdvanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06468644
What this trial is testing

Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 60
Early research (Phase 1)Study completedNCT02791334
What this trial is testing

Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Instability-High (MSI-H) Solid TumorsCutaneous Melanoma+2 more
Eli Lilly and Company 164
Large-scale testing (Phase 3)Looking for participantsNCT05646511
What this trial is testing

TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
National Cancer Center Hospital East 608
Testing effectiveness (Phase 2)Study completedNCT03684811
What this trial is testing

FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

Who this might be right for
Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme)Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas)Cohort 3a and 3b: Chondrosarcoma+2 more
Forma Therapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT00303771
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 282
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Next Page
93